Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis - a Randomized, Multicentre, Non-inferiority, Open Label Trial

NCT06907316 is registered in ClinicalTrials.gov with Bulovka Hospital as lead sponsor.

NCT NCT06907316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06907316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis - a Randomized, Multicentre, Non-inferiority, Open Label Trial
Lead sponsor
Bulovka Hospital
Phase
Phase 4
Overall status
Terminated
Start date
July 13, 2021
Completion date
August 1, 2024
Enrollment
61 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

syphilis